|
Video ViewPoint Strategy Session: Rethinking the Management of Differentiated and Anaplastic Thyroid Cancers
Gain expert insight and strategies for the management of anaplastic thyroid cancer including emerging data on immunotherapies, and treatment to manage adverse events. This activity is presented by leading experts, Jochen Lorch, MD, MSc, Director Thyroid Cancer Center, Dana-Farber Cancer Institute, and Carolyn Grande, CRNP, AOCNP®, Oncology Nurse Practitioner, Abramson Cancer Center.
STATEMENT OF NEED
Thyroid cancer is one of the most prevalent cancers in the United States. An estimated ... |
|
|
Metastatic Triple-Negative Breast Cancer: Applying Treatment Advances to Personalized Care
Sara A. Hurvitz, MD, FACP, Director of the Breast Cancer Clinical Trials Program at the David Geffen School of Medicine at UCLA, and a prominent authority on TNBC, provides perspectives on personalized care plans for patients with metastatic TNBC, efficacy and safety of emerging treatments, strategies to improve quality of life for patients with metastatic TNBC, and much more! Start the activity now!
STATEMENT OF NEED
With an estimated 284,200 new cases per year, breast cancer is the mo... |
|
|
Podcast: Novel and Emerging Treatment Strategies for Advanced Classical Hodgkin Lymphoma
Discover new and emerging treatment strategies for advanced classical Hogkin lymphoma, personalized care plans, and best practices for managing supportive care need. This activity is presented by leading experts Kami Maddocks, MD, Professor of Clinical Internal Medicine, Lymphoma Program Director, The James Cancer Hospital at The Ohio State University, and Kelly Brassil, PhD, RN, FAAN, Advanced Practice Nurse, University of Texas MD Anderson Cancer Center. Start the activity now!
STATEMENT ... |
|
|
Video Viewpoint Strategy Session: Novel and Emerging Treatment Strategies for Advanced Classical Hodgkin Lymphoma
Discover new and emerging treatment strategies for advanced classical Hogkin lymphoma, personalized care plans, and best practices for managing supportive care need. This activity is presented by leading experts Kami Maddocks, MD, Professor of Clinical Internal Medicine, Lymphoma Program Director, The James Cancer Hospital at The Ohio State University, and Kelly Brassil, PhD, RN, FAAN, Advanced Practice Nurse, University of Texas MD Anderson Cancer Center. Start the activity now!
STATEMENT ... |
|
Acromegaly Highlights from ENDO 2021
This CME activity highlights the latest research about Acromegaly that was presented at ENDO 2021, the annual meeting of the Endocrine Society. This activity provides expert analysis on that research and its clinical relevance for busy members of the care team in order to help them care for patients with acromegaly. |
|
|
Video Viewpoint Strategy Session: Advances in the Treatment of Relapsed/Refractory Immune Thrombocytopenia
Learn new advances in the treatment of relapsed or refractory immune thrombocytopenia, including treatment differentiation, efficacy and safety strategies, and much more. This activity features perspectives from two noted experts in the field, Dr. Keith McCrae, Director of Benign Hematology at the Cleveland Clinic Taussig Cancer Center; and Ms. Phyllis McKiernan, Advanced Practice Nurse in Blood & Marrow Stem Cell Transplantation at the John Theurer Cancer Center, Hackensack Meridian Health.
... |
|
|
Enhancing the Clinical Outcomes of Patients with Extensive–Stage Small Cell Lung Cancer
Anne Chiang, MD, PhD, Yale School of Medicine, a leading expert on small cell lung cancer, for an in-depth presentation on patient outcomes in extensive-small cell lung cancer. Dr. Chiang will present evidence-based advice regarding emerging therapies, strategies for targeted treatments and immunotherapy, optimization of individual patient treatment plans, managing adverse events, and much more! Start the activity now!
An estimated 228,820 new cases of lung cancer are reported in the United... |
|
|
New Perspectives on Diagnosis and Treatment of EGFR Exon 20 Insertion–NSCLC
Discover new developments in the diagnosis and treatment of EGFR exon-20 Insertion–Mutant NSCLC and assess emerging efficacy and safety data on novel targeted therapies. This activity features expert insights from Helena Yu, MD, Memorial Sloan Kettering Cancer Center, and Maria Arcila, MD, Memorial Sloan Kettering Cancer Center.
This activity is also available as a podcast.
An estimated 235,760 new cases of lung cancer are reported in the United States annually, and 131,880 people die... |
|
|
Current and Emerging Therapies for Lysosomal Storage Disease
This continuing education activity is provided through collaboration between the Lysosomal and Rare Disorders Research and Treatment Center (LDRTC), CheckRare, and AffinityCE. This activity provides continuing education credit for physicians, physician assistants, nurses, nurse practitioners, and genetic counselors. A statement of participation is available for other attendees. |
|
|
An Interactive Guide to the Underdiagnosed, Underestimated, but Treatable Metabolic Disorders
This infographic activity uses a self-directed, visual update to the state-of-the-art diagnosis and management of treatable lysosomal storage disorders. Much of what you learned in your primary training may be outdated because of rapid advances in genetic, molecular, and clinical approaches to these conditions. While the LSDs were often fatal conditions, new treatments have completely changed the possible outcomes for patients, but a major barrier is recognition of the condition in time for tr... |
|
|
New Opportunities in Advanced KRAS Mutation-Positive NSCLC
In this CME/NCPD activity, D. Ross Camidge, MD, PhD, of the University of Colorado, and Beth Sandy, MSN, CRNP, OCN®, of the University of Pennsylvania, discuss novel treatments for advanced KRAS mutation-positive NSCLC and how to manage adverse events associated with small molecule inhibitors. Start now!
An estimated 228,820 new cases of lung cancer are reported in the United States annually, and 135,720 people die of the disease (ACS, 2020). Approximately 84% of cases are classified as... |
|
|
Fabry Disease Research Highlights
At WORLDSymposium 2021, new information and data were presented on Fabry disease, a rare lysosomal storage disorder. This CME activity highlights the latest information about Fabry disease from WORLDSymposium 2021 and provides expert analysis of its clinical relevance for busy members of the care team in order to help them care for patients with this rare condition. |
|
|
Gaucher Disease Research Highlights: ASH 2020
At the American Society of Hematology Annual Meeting (ASH 2020), new information and data were presented on Gaucher disease, a rare lysosomal storage disorder, that requires a team of health care professionals to properly manage. This CME activity highlights the latest information about Gaucher disease from ASH 2020 and provides expert analysis of its clinical relevance for busy members of the care team in order to help them care for patients with this rare condition.
Activity Faculty
|
|
|
Meeting the Challenges in Management of Sickle Cell Disease
No longer a life-threatening disease, sickle cell disease (SCD) has become a chronic disease with life-threatening events that requires coordinated care by a multidisciplinary care team. Join Michael R. DeBaun, MD, MPH, and Collin Montgomery, APRN, as they discuss the acute and chronic complications experienced by individuals with SCD and the barriers they often encounter. The faculty offer real-world strategies for overcoming these barriers to improve the quality of life and other health outc... |
|
|
Update on Therapeutic Advances in T-Cell Lymphoma
Join Steven M. Horwitz, MD, Member and Attending Physician at Memorial Sloan Kettering Cancer Center, as he discusses guideline recommendations for differential diagnosis of TCL, novel treatment strategies, and best practices for managing side effects in this case-based CME/NCPD activity!
STATEMENT OF NEED
Each year, 74,240 new cases of non-Hodgkin lymphoma are diagnosed and 19,940 people die of the disease (ACS, 2020). Among these cases, 12% to 15% are classified as peripheral T-cell l... |
|
|
Optimizing the Management of Moderate-to-Severe Atopic Dermatitis in Adult Patients
STATEMENT OF NEED
Atopic dermatitis is a severe form of eczema pathologically characterized by skin barrier disruption mediated by a type 2 helper T-cell immune response. The incidence of atopic dermatitis is high, estimated to be approximately 15% to 20% in children and 1% to 3% in adults worldwide (Avena-Woods, 2017). In addition to the hallmark clinical symptoms of eczema and intense pruritus, atopic dermatitis is associated with a substantial and multifaceted patient-reported burden tha... |
|
Expert Updates in COVID19: An Animated Video Series
Five animated videos clearly explain managing patients with COVID19, lung disease, ARDS, or long-COVID. Hear from the leading pulmonologists on best practices based on the latest literature. |
|
|
Assessing a Patient With Long COVID-19: An Interactive Case Scenario
In this interactive case, the physician recommends a series of assessments for your patient with Long-COVID symptoms. For each assessment, the user chooses the outcome to hear recommendations from the experts. |
|
|
TEAM UP: Defining and Refining Optimal HIV Care During the COVID-19 Pandemic
In this webcast series, members of the DAP Health team review key data and discuss their real-world experiences providing care for persons living with HIV during the COVID-19 pandemic. DAP Health opened one of California’s first COVID-19 clinics and hotlines to offer screening, testing, and treatment.
Topics covered in this webcast series include:
COVID-19–Related Complications in Persons Living With HIV (PLWH);
COVID-19 Testing Strategies;
Home Care for PLWH Diagnosed With COVID-1... |
|
|
Eye on Neuromyelitis Optica Spectrum Disorder (NMOSD)
Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune disease often characterized by sporadic and repeated inflammatory flare ups that can impact the optic nerve and/or spinal cord. With each repeated attack, additional permanent neurological damage will accrue. This CME activity highlights the important role both ophthalmologists and neurologists play in diagnosing and treating NMOSD most efficiently. |
|
|
Pulmonary Arterial Hypertension (PAH) Highlights from CHEST 2020
Although CHEST 2020 was not a live, in-person meeting, new information and data regarding pulmonary arterial hypertension (PAH) will still be published but will not be easily accessible to the care team involved in the diagnosis and management of patients with this rare disease who need to know and incorporate the latest information into patient care. This CME activity highlights the latest research on PAH to help clinicians keep up to date on the most efficient ways to manage their patients. |
|
|
Understanding Evolving Therapeutic Strategies for Graft-Versus-Host Disease (Module 1: Diagnosis, Risk Assessment, and Staging; Module 2: Current and Emerging Therapeutic Strategies)
STATEMENT OF NEED
Graft-versus-host disease (GVHD) is a major complication of allogeneic hematopoietic stem cell transplant (HSCT), affecting between 40% and 60% of patients and accounting for 15% of posttransplant mortality. Acute GVHD is the second-leading cause of transplant-related mortality and typically targets the skin, gastrointestinal tract, and liver. Chronic GVHD often presents during the first year following HSCT but may develop in subsequent years and most commonly affects the ... |
|
|
Optimal Prehospital Management of Seizure Emergencies
In this program, the faculty will review and provide updates on the guidelines for managing seizure emergencies and address how participants can reduce the barriers to prehospital treatment through the use of Seizure Action Plans. They also will discuss recent clinical trials that may improve caregiver acceptance of rescue medications for status epilepticus. In addition, the faculty will address the similarities and differences in managing seizure emergencies for pediatric and adult patients. |
|
|
Research Updates in Gout: Improving Response Rate to Therapy
Dr. Brian Mandell and Dr. Naomi Schlesinger discuss recent published evidence related to gout, as well as study results presented at the American College of Rheumatology Convergence 2020 virtual annual meeting. Dr. Schlesinger begins with an introduction on a recent published systematic review indicating that the manifestations of gout extend beyond the joints, affecting other organs and tissues. Dr. Schlesinger also provides an overview of some of the challenges encountered in clinical practi... |
|
|
A Case-Based Roadmap for Improved Patient Outcomes in Psoriatic Arthritis
Patients with psoriatic arthritis (PsA) experience significant disease burden due to incomplete diagnostic evaluation and suboptimal use of effective therapies. In this case-based activity, Dr. Leonard Calabrese of the Cleveland Clinic addressing these practice gaps by sharing his recommendations for patient management at critical decision points in the diagnosis and treatment of patients with PsA. Dr. Calabrese also discusses the important role of shared decision-making over the course of the... |
|
|
Update on Immunotherapeutic Strategies for Advanced Merkel Cell Carcinoma
STATEMENT OF NEED
Merkel cell carcinoma is a rare and aggressive neuroendocrine tumor of unknown origin that typically presents in older white and immunocompromised adults. An estimated 2,488 cases are diagnosed in the United States annually (Paulson et al, 2018). The incidence of MCC has risen rapidly during the past few decades, which has been attributed in part to people living longer with increased sun exposure and weakened immune systems, a feature that suggests an infectious origin an... |
|
|
New Data and Clinical Perspectives on the Treatment of Metastatic Hormone-Sensitive Prostate Cancer
STATEMENT OF NEED
Prostate cancer is the most common tumor type affecting men in the United States. An estimated 191,930 new cases are diagnosed annually, and 33,330 people die from the disease (ACS, 2020). Most patients with metastatic hormone-sensitive prostate cancer (HSPC) present with relapse after local treatment, while approximately 5% of all prostate cancer patients present with de novo metastatic HSPC (Ng et al, 2020). The five-year overall survival rate for metastatic HSPC remains... |
|
|
Expert Guidance on New Advances in Renal Cell Carcinoma
STATEMENT OF NEED
Kidney cancer accounts for approximately 4% of all cancer diagnoses in the United States (ACS, 2020). An estimated 73,750 new cases are reported annually and 14,830 people die of the disease. Renal cell carcinoma, which comprises nearly 90% of all kidney cancers, is characterized by a lack of early warning signs, diverse clinical manifestations, and resistance to radiation and chemotherapy. Due to its often asymptomatic presentation, many patients have advanced disease at ... |
|
|
Virtual Tumor Board: Optimizing Personalized Care Plans for Patients With Metastatic Breast Cancer
STATEMENT OF NEED
Breast cancer accounts for approximately 30% of cancer diagnoses among women in the United States and is the second-leading cause of cancer death in this population (ACS, 2020). Although many women benefit from regular screening as well as earlier and improved treatment, approximately 6% present with metastatic disease, and up to 30% with no initial lymph node involvement eventually develop metastatic disease (Siegel et al, 2020; Mortensen et al, 2018). Women with metastat... |
|
|
Virtual Tumor Board: Optimizing Personalized Care Plans for Patients With Relapsed/Refractory Follicular Lymphoma
STATEMENT OF NEED
Of the estimated 74,200 new cases of non-Hodgkin lymphoma each year in the United States, approximately 22% are FL, an indolent, difficult-to-treat B-cell malignancy (ACS, 2019; NCCN, 2019). Most patients are diagnosed at an average age of 63 years (NCI, 2019). Despite the introduction of novel therapies during the past decade, complications such as delayed presentation and treatment and evolving disease subtypes continue to hamper patient outcomes, and multiple recurrence... |
|
|
Virtual Tumor Board: Optimizing Personalized Care Plans for Patients With Advanced Soft Tissue Sarcoma
STATEMENT OF NEED
Soft tissue sarcomas are a heterogeneous group of malignancies that arise primarily from the mesodermal tissues of the extremities, trunk and retroperitoneum, and head and neck. An estimated 13,130 new cases are diagnosed in the United States annually and 5,350 people die of the disease. Surgical resection is the mainstay of treatment for localized soft tissue sarcoma, with radiation and chemotherapy commonly used as adjuncts. However, nearly 50% of patients will experienc... |
|
|
Navigating the Recent Rheumatoid Arthritis Guidelines to Achieve Disease Remission and Reduce Patient
Roy M. Fleischmann, MD, discusses the latest evidence for the management of patients with moderate-to-severe rheumatoid arthritis who do not achieve treatment goals with initial disease-modifying anti-rheumatic drug therapy. A key treatment principle emphasized by Dr. Fleischmann is using a treat-to-target approach guided by validated tools for assessing disease activity and patient-reported outcomes. Among the treatment options, Dr. Fleischmann highlights the pharmacology of the latest approv... |
|
|
Navigating Advancements in Diagnosis & Treatment of Axial Spondyloarthritis
More than 80% of the population has significant back pain at some point in their life, with 30% of adults in the United States stating they have chronic low back pain at any given time; 5% of whom have inflammatory back pain. Axial spondyloarthritis (axSpA) affects almost 1.5% of patients with inflammatory back pain; however, the majority of individuals suffering with back pain are not being treated by a rheumatologist, which only exacerbates the challenge to diagnose those with axSpA.
Dr.... |
|
|
Research Developments in Atopic Dermatitis
Welcome to this activity focusing on new research related to atopic dermatitis presented as posters at the 2020 virtual annual meetings of the American Academy of Dermatology and the American Academy of Allergy, Asthma, and Immunology. The posters focus on new data related to the use of advanced therapies for atopic dermatitis. Beyond discussing the methods and results of each poster, the faculty, Drs. Steven Feldman and Alan Fleischer, Jr., share their views on the implication of the trial re... |
|
|
Defining Personalized Care Plans in Metastatic Colorectal Cancer
STATEMENT OF NEED
Colorectal cancer (CRC) is the third leading cause of cancer death among men and women in the United States. An estimated 145,600 new cases are diagnosed annually and 51,020 people die of the disease. When detected and treated early at a localized stage, the 5-year survival rate is 90%. However, because CRC initially exhibits no symptoms and the use of routine screening is suboptimal, most patients are diagnosed at later stages. Approximately 21% of patients present with m... |
|
|
Tumor-induced Osteomalacia (TIO): Diagnosis and Management
Tumor-induced osteomalacia (TIO) is a rare paraneoplastic condition commonly characterized by bone pain, muscle weakness and fractures. These tumors secrete excess fibroblast growth factor 23 (FGF23) which inhibits the sodium phosphate renal co-transporters and suppresses 1α hydroxylase activity, thereby decreasing renal reabsorption and increased urinary phosphate excretion. As a result, unexplainable hypophosphatemia with a variety of musculoskeletal abnormalities are the most common sympto... |
|
|
Food Allergy: From Primary Prevention to Treatment and Intervention Online
This online offering includes 19 videos of lectures and panel discussions on the diagnosis and management, specific syndromes, treatment, and research and prevention of food allergy. The videos were recorded at a live course that took place at a live AAAAI course held in early September, 2019.
The intent of the videos is to allow learners to increase their knowledge related to the diagnosis and management of food allergic patients. It highlights the latest evidence related to food allergie... |
|
|
Conversations from the World of Allergy: Podcast Episodes for Credit
This podcast features interviews on a wide variety of allergy/immunology topics. It is our hope that the conversations provide evidence-based information that is useful to clinicians, researchers and patients, alike.
Some episodes are available for CME credit. All podcast episodes are available at https://www.aaaai.org/professional-education-and-training/podcasts |
|
|
On a Limb: How Can We Better Optimize PAD Care?
Are your patients with PAD post-revascularization “on a limb”? Find out as Marc Bonaca, MD, MPH covers the latest guideline recommendations and clinical trial data related to managing patients with PAD post-revascularization. This expert perspective provides clinicians with practical insights to apply to their practice.
The purpose of this activity is to provide learners with an engaging, practical presentation to help them optimize anticoagulant therapy in their patients with PAD post-... |
|
|
Kansas City Heart Rhythm Symposium
COMPLIMENTARY REGISTRATION! (Virtual and In-Person)
The purpose of the Kansas City Heart Rhythm Symposium is to update medical practitioners on the future of cardiac electrophysiology (EP), and on new diagnosis and treatment guidelines in the care and management of patients with arrhythmias, heart failure and other issues impacting the electrical system of the body. Participants will learn about advances in ablation techniques, device management, appropriate use criteria, and survey new dev... |
|
|
Oral Combination Therapy: The PAtH to Improved Patient Care in PAH
Are you interested in finding out how you can more effectively manage your patients with PAH? In this short “How I Do It” vlog, expert faculty Dr. Vallerie McLaughlin, Director of the Pulmonary Hypertension Program at the University of Michigan discusses recommendations for the use of oral combination therapies in PAH along with her experiences and considerations with these treatment options in clinical practice. Stay on the right PAHth with therapeutic options available for your patients ... |
|
|
Targeting Plaque Psoriasis: Systemic Therapy for A Systemic Disease
Program Overview
This interactive activity incorporates cases to provide up-to-date information for PAs on assessing the severity of psoriasis, identifying comorbid conditions, advances in systemic treatment, and referring patients to psoriasis specialists.
Learning Objectives
Upon completion of this activity, participants should be better able to:
Describe the clinical features of psoriasis
Discuss the assessment of psoriasis severity
Recognize comorbid conditions commonly seen ... |
|
|
Management of Cancer Pain: Current Guidelines
STATEMENT OF NEED
Patients with cancer often suffer from a range of symptoms that negatively impact their quality of life. Among the most significant of these symptoms is pain, which can be caused by surgery, radiation, chemotherapy, targeted therapy, diagnostic procedures, and/or supportive care measures. Between 20% and 50% of patients with cancer experience pain, including moderate-to-severe pain, in approximately 80% of patients with advanced-stage cancer (NCI, 2021). Despite awareness ... |
|
|
Advances in GI - via Livestream
Advances in GI will bring together multidisciplinary experts to update your knowledge of gastrointestinal and hepatological diseases and their management.
Get the information you need to improve patient outcomes in a variety of settings, from internal medicine to geriatrics. Clinicians from Virginia Mason’s Center for Digestive Health will take on gripping clinical challenges commonly seen in primary care, including: diagnosis and treatment of gastroesophageal reflux disease and paraoesop... |
|
|
Transforming the Modern Management of Relapsing Multiple Sclerosis
In this activity Patricia Coyle, MD and Amy Perrin Ross, APN, MSN, CNRN, MSCN discuss the current management of MS, with a special focus on assessing and monitoring patients’ cognitive health. |
|
|
From Risk Assessment to Treatment: Real-World Approaches to PAH
In this clinical commentary, join cardiology expert Dr. Vallerie McLaughlin, Director of the Pulmonary Hypertension Program at the University of Michigan and pulmonology expert Dr. Victor Tapson, Director, Pulmonary Vascular Disease Research at Cedars-Sinai Medical Center as they provide real-world advice on the management of pulmonary arterial hypertension (PAH). These experts will discuss their best practices for:
• Risk assessment and stratification
• Use of oral combination therapies... |
|
|
COVID-19 In the Pipeline Therapeutics
Target Audience
This activity is intended for health care providers in the care of patients with COVID-19.
This activity is supported by independent educational grants from Regeneron Pharmaceuticals Inc., Gilead Sciences Inc., and Eli Lilly and Company.
Program Overview:
In this on-demand video webinar, Dr. Paul Auwaerter discusses potential COVID-19 treatments currently in the pipeline. Topics:
Outpatient treatments: inhaled remdesivir, oral antivirals, inhaled budesonide, and monoclon... |
|
|
DOACs in Transition: Examining the Challenges and Complexity of Transitions in Care
Why should hospitalists, cardiologists, and other clinicians care about optimal post-discharge prophylaxis in patients with acute medical illness? What strategies are available to better ensure optimal post-discharge prophylaxis in this patient population? This clinical commentary features leading thrombosis expert, Dr. Alex Spyropoulos, and a multidisciplinary panel, covering these important questions and how clinicians can ensure that they optimally incorporate these recommendations into the... |
|
|
7-Night Alaska CME AWAY® Cruise
Vancouver, British Columbia • Sitka, Alaska • Hubbard Glacier, Alaska (Cruising) • Juneau, Alaska • Ketchikan, Alaska |
|
|
7-Night Alaska CME AWAY® Cruise - Forensic Dentistry, Domestic Violence, Oral Cancer and HPV and Psychiatric Illness and Dentistry: Challenges for Oral Care
Vancouver, British Columbia • Sitka, Alaska • Hubbard Glacier, Alaska (Cruising) • Juneau, Alaska • Ketchikan, Alaska |
|